The Drugs Controller General of India (DCGI) gave emergency use clearance to single-dose Sputnik Light Covid vaccination in India on Sunday, February 6, 2022, to battle the dangerous Covid-19 virus. "DCGI has granted emergency use authorization to Single-dose Sputnik Light COVID-19 vaccination in India," said Union Minister for Health Dr Mansukh Mandaviya in a tweet. This is the country's ninth COVID-19 vaccination." He went on to say that this measure will help the country's joint fight against the pandemic.
Days after suggestions were presented during an SEC (Subject Expert Panel) meeting on January 31, Russia's Sputnik Light Covid vaccine was granted emergency use permission (EUA). Dr Reddy's Laboratories submitted a request to the DCGI for approval to register Sputnik Light Vaccine as a booster dosage against Covid-19 and to import Sputnik Light for restricted use in an emergency. It's worth noting that Dr Reddy's Laboratories, a Hyderabad-based pharmaceutical company, cooperated with the Russian Direct Investment Fund (RDIF) to undertake clinical testing of the Russian Covid Vaccine – Sputnik V and then market the vaccine in India in September 2020.
What is Sputnik Light?
The original Vaccine Sputnik V is Russia's flagship two-dose Covid-19 vaccine, developed by Russia's Gamaleya Research Institute of Epidemiology and Microbiology. The country announced the distribution of the one-dose Sputnik Light vaccine last year. It is necessary to have a thorough understanding of Sputnik to comprehend Sputnik V Light. Sputnik V is made up of two adenoviruses that must be delivered by two different vaccinations. The first dose of this vaccine comprises adenovirus type 26 (AD26), whereas the second dose contains adenovirus type 5 (AD5) and is given after a 21-day delay (AD5).
The initial component of the first dose of Sputnik V – (recombinant human adenovirus serotype number 26 (rAd26) – now makes up the Sputnik V Light. Sputnik V is a safe and licensed stand-alone one-shot vaccine, according to the company's official website. Argentina, Russia, and other nations have licensed the Sputnik Light vaccine. Over 2.5 billion people reside in nations where Sputnik Light has been licensed as a solo vaccination as well as a universal booster.
According to the Russian Direct Investment Fund (RDIF), Sputnik Light was 70% effective against infection caused by the delta variant. The use of Sputnik Light for heterologous boosting can improve the efficacy and durability of other vaccinations, particularly those against the Omicron variety.
Covishield and Covovax from the Serum Institute of India, Covaxin, and Corbevax from Bharat Biotech, ZyCoV-D by Zydus Cadila, Spikevax by Moderna, Ad26.COV2.S – Janssen by Johnson & Johnson, and Vaxzevria by AstraZeneca have all been authorized for emergency use in India.
Tags : #sputnik #russia #covid19 #vaccine #death #emergency #clearance #healthministry